Literature DB >> 22375716

BRCA1 haploinsufficiency: consequences for breast cancer.

Leonardo Salmena1, Steven Narod.   

Abstract

In their study, Konishi et al. generate and study cell lines that carry one mutant and one normal copy of BRCA1. These heterozygous (noncancerous) cells are noteworthy in that they carry an increased number of copy number alterations and have diminished DNA repair capacity. These observations go beyond the classical two-hit hypothesis for inherited cancers, whereby the cell phenotype is normal until the second allele is lost through somatic mutation or epigenetic silencing. They propose that BRCA1 heterozygosity is associated with increased genomic instability, which accelerates the mutation rate of other critical genes, including the second copy of BRCA1. They conclude that BRCA1 is a haploinsufficient tumor suppressor gene, which when lost through inheritance, increases a cell's susceptibility to acquire further mutations.

Entities:  

Mesh:

Year:  2012        PMID: 22375716     DOI: 10.2217/whe.12.2

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  6 in total

1.  Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.

Authors:  Lubomir Balabanski; Georgi Antov; Ivanka Dimova; Samuil Ivanov; Maria Nacheva; Ivan Gavrilov; Desislava Nesheva; Blaga Rukova; Savina Hadjidekova; Maxim Malinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2014-02-04

Review 2.  BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.

Authors:  Atsuko Nakanishi; Akari Minami; Yasuko Kitagishi; Yasunori Ogura; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2015-01-28       Impact factor: 5.923

3.  BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane.

Authors:  J Kotsopoulos; S Zhang; M Akbari; L Salmena; M Llacuachaqui; M Zeligs; P Sun; S A Narod
Journal:  Br J Cancer       Date:  2014-07-15       Impact factor: 7.640

4.  Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific.

Authors:  Rania Chehade; Rachael Pettapiece-Phillips; Leonardo Salmena; Max Kotlyar; Igor Jurisica; Steven A Narod; Mohammad R Akbari; Joanne Kotsopoulos
Journal:  Breast Cancer Res       Date:  2016-08-17       Impact factor: 6.466

5.  Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.

Authors:  Annelot Baert; Julie Depuydt; Tom Van Maerken; Bruce Poppe; Fransiska Malfait; Katrien Storm; Jenneke van den Ende; Tim Van Damme; Sylvia De Nobele; Gianpaolo Perletti; Kim De Leeneer; Kathleen B M Claes; Anne Vral
Journal:  Breast Cancer Res       Date:  2016-05-17       Impact factor: 6.466

6.  Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.

Authors:  Elisabet Cuyàs; Salvador Fernández-Arroyo; Tomás Alarcón; Ruth Lupu; Jorge Joven; Javier A Menendez
Journal:  Oncotarget       Date:  2016-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.